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Up to 50% of recurrences of ductal carcinoma in situ of the breast are associated with invasive carcinoma but no pathological
or molecular features have yet been found to predict for the development of invasive disease. For a tumour to invade, it
requires the formation of new blood vessels. Previous studies have described a vascular rim around ducts involved by ductal
carcinoma in situ, raising the possibility that the characteristics of periductal vascularisation may be important in determining
transformation from in situ to invasive disease. Periductal vascular density and phenotype were determined using morphometry
and a panel of anti-endothelial antibodies (von Willebrand factor, CD31, CD141 and CD34) and related to the presence of
invasive carcinoma and other histological features. Compared to normal lobules, pure ductal carcinoma in situ exhibited a
greater density of CD34
+ and CD31
+ vessels but a decrease in those that were immunopositive for vWF, indicating a
difference in phenotype and in density. Ductal carcinoma in situ associated with invasive carcinoma showed a proﬁle of
vascular immunostaining similar to that of pure ductal carcinoma in situ but there were signiﬁcantly greater numbers of CD34
+
and CD141
+ vessels and fewer staining for vWF. There was a signiﬁcant negative correlation between vascular density and
both the cross-sectional areas of the ducts involved and the extent of the necrosis of the tumour they contained. A
correlation between vascular density and nuclear grade was also noted, being highest in the intermediate grade. The greater
density of CD34
+ and CD141
+ vessels around ductal carcinoma in situ associated with invasive carcinoma could reﬂect a
greater predisposition to invade but a direct effect of co-existent invasive carcinoma cannot entirely be ruled out in the
present study. The relationship between vascular density, grade, duct size and nuclear grade suggests that periductal
angiogenesis increases with tumour growth rate but is unable to keep pace with the most rapidly growing lesions.
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With the advent of screening mammography, the frequency with
which ductal carcinoma in situ (DCIS) is detected has increased
from approximately 1 to 20% of all breast cancers and is as high
as 30% in some centres (Nemoto et al, 1980; Fryberg and Bland,
1994). Histological grade, lesion size and excision margin status
are strongly related to the probability of developing local recur-
rence (Recht et al, 1985; Silverstein et al, 1995; Badve et al,
1998) and important in determining management. Recurrent in
situ carcinoma is itself innocuous but up to 50% of recurrences
are associated with invasive carcinoma (Recht et al, 1985; Silver-
stein et al, 1995; Badve et al, 1998). To date, no pathological or
molecular features have been found to predict for the development
of invasive disease.
For a tumour to grow beyond 1–2 mm
3, it requires the
formation of new blood vessels to supply oxygen and nutrients
as well as to excrete catabolites. There have been many studies
of the process of angiogenesis in breast carcinoma but most have
focused on invasive disease. In DCIS and other precursor lesions
(Guidi et al, 1994; Engels et al, 1997a,b; Lee et al, 1997; Lee et
al, 1999; Sales et al, 1999; Valtola et al, 1999), two patterns of
vascularity have been described: diffuse stromal vascularity and
a vascular rim around the involved ducts. Pre-malignant lesions
of the breast can induce angiogenesis in animal experimental
systems and in the human breast (Gimbrone and Gullino,
1976; Brem et al, 1977; Heffelﬁnger et al, 1996; Lichtenbeld et
al, 1998), it thus seems possible that the pattern or extent of
vascularisation around DCIS may be an important factor in
determining the transformation from in situ to invasive carcino-
ma. It is likely that the periductal vessels are most important in
this respect as incipient invasion is most likely to be associated
with changes in vessels in the immediate vicinity of the tumour
cells.
The main aim of this study was to test the hypothesis that the
development of invasive carcinoma in DCIS is associated with
changes in periductal vessels. The phenotype and number of micro-
vessels were compared in pure DCIS with those in DCIS associated
with invasive carcinoma. As studies of breast cancer angiogenesis in
the past have been associated with inconsistent ﬁndings, we have
used precise morphometric methodology to compare vascularity
in DCIS with normal breast and have employed a panel of anti-
endothelial antibodies to take account of phenotypic as well as
numerical changes. At the same time we have taken the opportu-
nity to determine if vascular density and phenotype have any
relationship to histological features, particularly nuclear grade,
necrosis and duct size.
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Patients and tumours
Formalin-ﬁxed parafﬁn-embedded breast samples (n=40) of
patients with ductal carcinoma in situ, with (n=20) and without
(n=20) invasive carcinoma, were collected from the archives of
the Pathology Department of the Royal Liverpool University
Hospital. The original haematoxylin and eosin (H&E) stained
sections of the primary tumours were reviewed by two pathologists
(BS Shoker and JP Sloane) for classiﬁcation by architecture and
nuclear grade following the guidelines of the European Commis-
sion and UK National Breast Screening Programme (National co-
ordinating group for breast screening pathology 1997, The consen-
sus conference committee 1997). A representative block for each
patient was selected for subsequent immunostaining.
Immunohistochemistry
Sections were stained for endothelial cells using monoclonal anti-
CD31 (JC/70A, DAKO, Denmark), anti-CD34 (Qbend/10, DAKO,
Denmark), anti-CD141 (Anti-Thrombomodulin, DAKO, USA)
and polyclonal anti-human von Willebrand factor (vWF) (DAKO,
Denmark).
Sections were dewaxed through two changes of xylene and
industrial methylated spirits (IMS). Endogenous peroxidase activity
was blocked with a mixture of H2O2/methanol (12 ml H2O2 in
400 ml methanol) for 12 min. Antigen retrieval was performed
for the endothelial markers by treating the sections with 0.2 g of
trypsin and 0.4 g of calcium chloride in 440 ml Tris Buffered
Saline (TBS (50 mM Tris-HCl, 150 mM NaCl, pH 7.4)) at 378C
for 20 min. For Ki67 antigen retrieval was performed by immersing
the sections in 2000 ml of Ethylenediamine-Tetraacetic Acid
(Sigma Chemical, St Louis USA) and then boiling in a pressure
cooker for 8 min. Prior to staining with the polyclonal antiserum,
sections were treated with a mixture of 5% bovine serum albumen
(BSA)/TBS (1 g Bovine Serum Albumen in 20 ml TBS) for 10 min.
The antibodies were diluted 1:5 for anti-CD31, 1:10 for anti-
CD141, 1:20 for anti-CD34 and 1:1000 for anti-human vWF
and Ki67 in 5% BSA/TBS. The sections were incubated with
primary antibodies at room temperature for 40 min. Secondary
antibodies were incubated for 40 min using EnVision Labelled
Polymer (mouse or rabbit as appropriate). Sections were washed
with TBS between incubation steps. 33'diaminobenzidine, DAB
was used as a chromogen. The last two steps were carried out using
a commercial kit (DAKO EnVision TM
+ System, Peroxidase
(DAB), USA).
The cell nuclei were counter-stained with Haematoxylin in solu-
tion. The sections were dehydrated through four changes of IMS
and three changes of xylene before being mounted in resinous
mountant (DPX, BDH Laboratory supplies, UK). Omission of
the primary antibody was used as a negative control and the
microvessels of the normal adjacent breast tissue served as internal
positive controls.
Assessment of tumour vascularity
NB determined vascular density without knowing how the architec-
ture or nuclear grade had been classiﬁed. No scanning of stained
microvessels to identify ‘hot-spots’ at low magniﬁcation was underta-
ken. The assessment of completely transected involved ducts started
from the upper right of all stained sections, moving downwards and
to the left. All or the ﬁrst 50 foci (duct cross sections) encountered
were assessed on each section, thus eliminating selection bias.
In the assessment of DCIS accompanied by invasive carcinoma,
only those foci of DCIS that were at least 2 mm away from the
invasive component were evaluated to minimise detecting direct
local effects of the invasive disease.
Evaluation of DCIS area
The area of each individual focus of DCIS was measured at 6200
magniﬁcation using an image analysis system (Zeis Axiohome with
software version 3.0, Germany). In addition, the area with a
circumference 100 mm from the edge of an individual focus of
DCIS was measured. The area required for MVD assessment was
thus calculated by subtracting the former from the latter (Figure 1).
Counting microvessels
The microvessels within 100 mm around each DCIS focus were
counted at high magniﬁcation (6400). Eligible microvessels
included any immunostained endothelial cell or cluster of cells
around a visible lumen clearly separated from adjacent microvessels,
tumour cells and other connective tissue components (Figure 2). The
presence of red blood cells was not required. It was not possible to
distinguish blood and lymphatic vessels. Where vessels were in clus-
ters, each was counted as separate if it met the above criteria.
Controls
Normal breast lobules were used as internal controls and up to ﬁve
normal lobules were assessed for each case of DCIS. The normal
lobules were assessed only if they were situated more than 2 mm
from the nearest tumour.
Evaluation of degree of necrosis
As part of the histological assessment, the degree of necrosis was
semi-quantitatively assessed in sections of high grade DCIS from
patients with and without invasive disease. Each individual focus
of DCIS was given a score of 1–3. A score of 1 was given when
no necrosis was present in an individual focus of DCIS, a score
of 2 when between 1 and 50% necrosis was present and a score
of 3 when there was more than 50% necrosis.
The data for each duct space were analysed using the Kruskal-
Wallis method and Mann-Whitney U-test and by the 2-tailed
Spearman’s or Pearson’s Correlation coefﬁcient using SPSS soft-
ware (Version 10.0 for Window NT).
RESULTS
The two groups of DCIS were matched for nuclear grade, each
contained 7 low, 6 intermediate and 7 high nuclear grade cases.
Microvessel density in DCIS without invasive carcinoma
Normal lobules The highest values of MVD were obtained using
vWF followed by CD34, CD141 and CD31. The mean MVD was
signiﬁcantly different between antibodies (Mann-Whitney, highest
P=0.01) apart from between CD141 and CD34 (Mann-Whitney,
P=0.28). (Table 1; Figure 3).
DCIS For DCIS the highest MVD was obtained using the antibody
to CD34, followed by CD141, vWF and CD31. In comparison to
normal lobules there were increases in CD34, CD141 and CD31 posi-
tive vessels but a decrease in those immunopositive for vWF. Changes
in MVD detected by the CD34, CD31 and vWF antibodies were
statistically signiﬁcant (Mann-Whitney, highest P=0.015) (Table 1).
MVD around DCIS using CD34 was less than that around normal
lobules using anti-vWF. However, the difference was not statistically
signiﬁcant (Mann-Whitney, P=0.35).
Microvessel density in DCIS with invasive carcinoma
Normal lobules In normal lobules surrounding cases of pure
DCIS, MVD was highest when stained with vWF, whereas the
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British Journal of Cancer (2002) 86(6), 905–911 ã 2002 Cancer Research UKnormal lobules surrounding areas of invasive carcinoma and DCIS
had the highest MVD with CD34. However, the only signiﬁcant
differences between the antibodies were that CD31 gave lower
values than the other three (Mann-Whitney, highest P50.001)
(Table 1). The MVD in normal lobules with DCIS and invasive
cancer obtained with vWF was signiﬁcantly lower than in normal
lobules from cases of pure DCIS (Mann-Whitney, P=0.014)
whereas those obtained with CD31, CD34 and CD141 showed no
signiﬁcant difference (Mann-Whitney, lowest P=0.2).
DCIS In DCIS, the highest MVD was obtained using the CD34
antibody. There were signiﬁcant differences among all four antibo-
dies (Mann-Whitney, highest P=0.034). (Table 1). In DCIS with
invasive carcinoma, in common with cases of pure DCIS, there
was an increase above normal in CD31, CD34 and CD141 but a
decrease in vWF immunopositive vessels. All these changes were
statistically signiﬁcant (Mann-Whitney, highest P=0.03). When
DCIS with invasive cancer compared with pure DCIS, we showed
an increase in MVD as determined by CD34 and 141 and decreases
as determined by CD31 and vWF. These ﬁndings were all statisti-
cally signiﬁcant (Mann-Whitney, highest P=0.001) except for CD31
(Mann-Whitney, P=0.3).
Relationship between MVD and nuclear grade
MVD increased from low to intermediate nuclear grade but
decreased in high grade DCIS usually to a level below that of
low grade. The difference between low and intermediate grade
DCIS was statistically signiﬁcant for pure and invasive cases using
all antibodies (Mann-Whitney, highest P=0.007) except for pure
DCIS when MVD was determined using vWF (Mann-Whitney,
P=0.07). The difference between intermediate and high grade was
signiﬁcant for both pure and invasive cases of DCIS with all anti-
bodies (Mann-Whitney, highest P50.001) except for invasive cases
when MVD was determined by CD31 (Mann-Whitney, P=0.4). The
difference between low and high grade, however, was signiﬁcant
only for pure DCIS using CD141, CD31 and vWF antibodies and
for invasive cases using CD31 (Mann-Whitney, highest P=0.047)
(Figure 4).
Relationship between MVD and core area
For all cases of DCIS the MVD fell with increasing size of the indi-
vidual focus of DCIS. This negative correlation was statistically
signiﬁcant as determined with all four antibodies (Spearmans,
highest P50.001) except when CD31 was used on cases of DCIS
associated with invasion (Spearmans, P=0.3) (Figure 5).
Relationship between MVD, core area and necrosis
As these analyses were restricted to high nuclear grade DCIS, cases
with and without invasive carcinoma were pooled. A signiﬁcant
negative correlation was observed between necrosis scores and
MVD using all four antibodies (Spearmans, highest P=0.002)
(Figure 6).
A signiﬁcant positive correlation was also observed between
necrosis scoring and core area of the foci for both pure DCIS
and DCIS associated with invasion (Spearmans, highest
P50.001) (Figure 7).
DISCUSSION
Angiogenesis has been shown to have prognostic signiﬁcance in
breast cancer (Weidner et al, 1991; Bosari et al, 1992; Horak et
al, 1992; Weidner et al, 1992) and several studies have shown that
pre-malignant lesions of the breast can induce angiogenesis in
animal experimental systems and in human breast (Gimbrone
and Gullino, 1976; Heffelﬁnger et al, 1996; Brem et al, 1977; Lich-
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Figure 1 Simpliﬁed diagram of an individual focus of ductal carcinoma in situ (DCIS) and peripheral area where the periductal microvessels were counted.
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(6), 905–911tenbeld et al, 1998). In 1976, Gimbrone et al (1976) showed that
30% of implants from pre-malignant murine hyperplastic alveolar
nodules showed angiogenesis on the irises of New Zealand White
rabbits. Furthermore, tissues of higher predicted tumour incidence
induced greater neo-vascular responses than did those with a lower
probability of malignant transformation. These ﬁndings have been
conﬁrmed in a number of similar studies (Guinebretiere et al,
1994; Brem et al, 1977; Lichtenbeld et al, 1998). We therefore felt
that it was reasonable to hypothesize that changes in periductal
vascularity may precede the development of invasive carcinoma
in DCIS.
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Figure 2 (A) Ductal carcinoma in situ (DCIS) stained immunohisto-
chemically using the CD34 antibody revealing a rim of positive vessels,
(B) same area stained for vWF. There is a striking difference in the number
of positive cells with the two antibodies in this case.
Table 1 The microvessel density (MVD) surrounding normal breast lobules and Ductal carcinoma in situ
(DCIS) using four differnet endothelial markers. (s.d.=standard deviation)
MVD stained MVD stained MVD stained MVD stained
with vWF antibody with CD31 antibody with CD141 antibody with CD34 antibody
(vessels mm
72) (vessels mm
72) (vessels mm
72) (vessels mm
72)
Normal lobules 106 (s.d.=74) 37 (s.d.=58) 80 (s.d.=77) 86 (s.d.=69)
(in patients with
Pure DCIS)
Normal lobules 78 (s.d.=50) 28 (s.d.=42) 85 (s.d.=75) 89 (s.d.=52)
(in patients with
DCIS and invasive
carcinoma)
Pure DCIS 84 (s.d.=64) 44 (s.d.=47) 88 (s.d.=64) 94 (s.d.=48)
DCIS (with 68 (s.d.=54) 41 (s.d.=36) 110 (s.d.=85) 116 (s.d.=72)
associated invasive
carcinoma)
A
B
Figure 3 (A) Non-cancerous lobules stained immunohistochemically
using the CD34 antibody revealing a rim of positive vessels, (B) same area
stained for vWF. There is also a striking difference in the number of positive
cells with the two antibodies in this case.
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diffuse stromal vascularity (pattern I) and a vascular rim around
the involved ducts (pattern II) (Guidi et al, 1994). Subsequently,
it was proposed that pattern II resulted from angiogenic factors
secreted by tumour cells and pattern I from recruitment of acces-
sory cells, which release angiogenic factors (Engels et al, 1997a). In
our study, we restricted our investigations to vascular pattern II as
we hypothesized that incipient invasion is likely to be associated
with vascular changes in the immediate vicinity of the tumour
cells.
In the present study the different antibodies used gave different
values for MVD both in normal lobules and DCIS indicating that
they identiﬁed different sub-populations of small vessels. In pure
DCIS, there was a signiﬁcant increase above normal in CD34
+
and CD31
+ vessels but a reduction in those staining for vWF.
These ﬁndings are in keeping with a change in phenotype as well
as vascular density.
In DCIS associated with invasive carcinoma, there were signiﬁ-
cantly greater numbers of CD34
+ and CD141
+ vessels and fewer
staining for vWF compared with pure DCIS. It is not clear whether
this higher periductal MVD reﬂects a greater predisposition to
invade or whether the effect is due to the proximity of invasive
carcinoma. We attempted to minimize the latter possibility by eval-
uating DCIS at least 2 mm from the nearest invasive carcinoma but
this would not exclude any effect of factors released by the tumour
into the blood or lymphatic system. It is of interest in this context
that the normal lobules from cases of invasive carcinoma exhibited
signiﬁcantly lower numbers of vWF
+ vessels than those from cases
of pure DCIS. This ﬁnding is in apparent conﬂict with the work of
Heffelﬁnger et al (1996) who found the vascularity of histopatho-
logically normal epithelium to be greater in breast containing
invasive carcinoma using an antibody to vWF. The breasts without
invasive disease in this study, however, included those with benign
proliferative change as well as DCIS.
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Figure 4 Relationship between microvessel density (MVD) and nuclear
grade in ductal carcinoma in situ (DCIS) without invasive carcinoma using
four types of endothelial markers. The boxes represent the mean values
and the whiskers represent 95% conﬁdence interval of the mean.
(LNG=low nuclear grade, ING=intermediate nuclear grade, HNG=high
nuclear grade).
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Figure 5 Relationship between microvessel density (MVD) and core
area in ductal carcinoma in situ (DCIS) without invasive carcinoma using
four types of endothelial markers. (1=vWF, 2=CD31, 3=CD141,
4=CD34).
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Figure 6 Relationship between microvessel density (MVD) and degree
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(6), 905–911The different antibodies used gave different values for MVD in
normal breast and showed dissimilar changes in DCIS. For patients
with and without invasive disease, vWF
+ vessels were at lower
density in DCIS than in the normal breast. This is in keeping with
observations on invasive tumours (colorectal carcinoma) where
vWF immunostaining has been found to be absent from some of
the capillaries in the tumour (Vermeulen et al, 1995). Anti-vWF
stains large vessels more strongly than small ones (Vermeulen et
al, 1996) and consequently our ﬁndings could reﬂect the immatur-
ity of newly formed tumour-associated vessels. The density of
CD34
+ vWF
- or CD141
+/vWF
- vessels could thus reﬂect the rate
tumour angiogenesis and the consequences it has for the biological
behaviour of DCIS.
CD31 gave consistently lower values for MVD than the other
antibodies. The molecule has a role in platelet adhesion in inﬂam-
mation and wound healing (Parums et al, 1990) and is expressed
on large and small vessels in either normal or tumour tissue
(Horak et al, 1992; Toi et al, 1993; Vermeulen et al, 1996). In
contrast to vWF it appears not to be expressed on lymphatic vessels
(Burgdorf et al, 1981) and this could at least partially explain why
determinations of MVD with the CD31 antibody were consistently
lower in both normal lobules and DCIS. The possible contribution
of lymphatics to neo-vascularisation in tumours has been largely
ignored.
Values for MVD as determined using CD34 and 141 antibodies
were roughly comparable both in normal lobules and DCIS. Both
showed a signiﬁcant increase in DCIS, with greater values in cases
associated with invasive carcinoma. Our ﬁndings conﬁrm those of
Martin et al (1997), that CD34 antibodies give consistently higher
vessel counts in breast carcinomas than antibodies against vWF or
CD31.
We found an unexpected relationship between MVD and nucle-
ar grade of DCIS. In those with and without invasive disease, the
MVD was signiﬁcantly higher in intermediate than either low or
high-grades. There was also a signiﬁcant negative correlation
between vascular density and both the cross-sectional areas of the
ducts involved and the extent of the necrosis of the tumour they
contained. The last ﬁnding is in apparent conﬂict with the study
of Guidi et al (1994), who found that comedo-type lesions were
more likely to be associated with higher microvessel density. In
their study, however, vessels up to 500 mm from the involved struc-
tures were included and only those from the ﬁve most vascular
ﬁelds were recorded. Vessels forming cuffs around ducts were
not studied quantitatively as they were found only in a minority
of cases. These authors, however, identiﬁed vessels using an anti-
body to vWF only, which in our study stained signiﬁcantly fewer
vessels than the CD34 and CD141 antibodies. A likely explanation
for our ﬁndings is that angiogenesis increases with growth rate but
is unable to keep pace with the most rapidly growing lesions. The
rapidly proliferating lesions tended to contain larger foci of DCIS
and often showed comedo necrosis.
In conclusion, the greater density of CD34
+ and CD141
+ vessels
around DCIS associated with invasive carcinoma could reﬂect a
greater predisposition to invade but a direct effect of co-existent
invasive carcinoma cannot entirely be ruled out in the present
study. The relationship between vascular density, grade, duct size
and nuclear grade suggests that periductal angiogenesis increases
with tumour growth rate but is unable to keep pace with the most
rapidly growing lesions.
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50% of DCIS focus has necrosis, (3) 450% of DCIS focus has necrosis).
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